FMSFresenius Medical Care AG

$21.06-13% 1Y

Is the price fair?

What FMS's price assumes

Fresenius Medical Care AG has no trailing P/E on file, so the price is measured against sales instead: 0.33× revenue.

0.33

Price / sales · no trailing P/E on file: measured against sales instead

Price / book
0.48

Price / book · as of 2025-Q4

EV / sales
0.79

EV / sales

Details›
Price / bookas of 2025-Q4
0.48
EV / EBITas of 2025-Q4
8.53
EV / salesas of 2025-Q4
0.79
Market capitalisation
$12.5B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.